WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
October 08, 2024 09:00 ET
|
WW International Inc.
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering,...
WeightWatchers Announces Executive Leadership Transition
September 27, 2024 08:00 ET
|
WW International Inc.
Independent Board Member Tara Comonte Will Serve as Interim Chief Executive OfficerSima Sistani Will Step Down as CEO and Director NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WW International,...
WeightWatchers Announces Strategic Leadership Team Appointments
September 10, 2024 09:06 ET
|
WW International Inc.
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) announced today the appointments of Scott Honken as Chief Commercial Officer and...